RAMAPO RIDGE PSYCHIATRIC
1. Target Overview & Investment Thesis
RAMAPO RIDGE PSYCHIATRIC is a 58-bed under-performing / distressed in BERGEN, NJ with $78.4M in net patient revenue and a -34.4% operating margin. The hospital serves a payer mix of 51.9% Medicare, 13.5% Medicaid, and 34.7% commercial.
Thesis: Turnaround. Our ML models identify $5.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -34.4% to -27.0% (+736bps).
| Net Revenue HCRIS | $78.4M |
| Current EBITDA COMPUTED | $-27.0M |
| Operating Margin COMPUTED | -34.4% |
| Occupancy HCRIS | 71.5% |
| Revenue / Bed COMPUTED | $1.4M |
| Net-to-Gross HCRIS | 76.0% |
| Distress Probability ML | 51.3% |
2. Market Context & Competitive Position
NJ has 95 Medicare-certified hospitals with a median operating margin of -3.9%. The target's margin of -34.4% places it below the state median. Among 29 size-comparable peers (29-116 beds), the median margin is -3.8%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (29-116), prioritizing same-state peers. 29 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| RAMAPO RIDGE PSYCHIATRIC (Target) | NJ | 58 | $78.4M | -34.4% |
| DEBORAH HEART AND LUNG CENTER | NJ | 85 | $211.9M | -5.5% |
| ST LUKES WARREN HOSPITAL | NJ | 92 | $200.8M | 28.1% |
| BERGEN NEW BRIDGE MEDICAL CENT | NJ | 101 | $187.0M | -39.4% |
| HUDSON REGIONAL HOSPITAL | NJ | 102 | $152.7M | 2.4% |
| CHILDRENS SPECIALIZED HOPSITAL | NJ | 68 | $150.1M | -18.1% |
| HACKENSACK UMC AT PASCACK VALL | NJ | 78 | $148.8M | 15.0% |
| HOBOKEN UNIVERSITY MEDICAL CEN | NJ | 114 | $133.9M | -48.9% |
| HACKETTSTOWN MEDICAL CENTER | NJ | 95 | $119.6M | 2.8% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $5.8M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.6M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.6M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.6M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $954K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $50K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-27.0M |
| + RCM Uplift | +$5.8M |
| Pro Forma EBITDA | $-21.2M |
| Current Margin | -34.4% |
| Pro Forma Margin | -27.0% |
| WC Released (1x) | $3.0M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-41.5M | $-120.1M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-41.5M | $-145.6M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-37.3M | $-140.0M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-37.3M | $-163.8M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-45.6M | $-135.5M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-45.6M | $-163.9M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| High | Elevated distress probability | Model estimates 51.3% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 29 hospitals with 29-116 beds
- Same-state prioritization (n=30)
- Comp margins: P25=-25.7% / P50=-3.8% / P75=9.5%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.